$TCON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tracon Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Tracon Pharmaceuticals, Inc.. Get notifications about new insider transactions in Tracon Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2021 | TCON | Tracon Pharmaceuti ... | PELLETIER SAUNDRA L | Director | Option Exercise | A | 6.55 | 10,500 | 68,775 | 10,500 | |
Jun 24 2021 | TCON | Tracon Pharmaceuti ... | WORLAND STEPHEN T | Director | Option Exercise | A | 6.55 | 10,500 | 68,775 | 10,500 | |
Mar 09 2021 | TCON | Tracon Pharmaceuti ... | Brown Scott B. | Chief Financial Off ... | Buy | P | 8.30 | 1,000 | 8,296 | 3,128 | 2.1 K to 3.1 K (+46.99 %) |
Mar 08 2021 | TCON | Tracon Pharmaceuti ... | Johnson-Pratt Lisa | Director | Option Exercise | A | 8.93 | 21,000 | 187,530 | 21,000 | |
Mar 08 2021 | TCON | Tracon Pharmaceuti ... | Johnson-Pratt Lisa | Director | Option Exercise | A | 8.93 | 21,000 | 187,530 | 21,000 | |
Jan 28 2021 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 8.98 | 11,000 | 98,771 | 201,232 | 190.2 K to 201.2 K (+5.78 %) |
Dec 30 2020 | TCON | Tracon Pharmaceuti ... | Ikarian Capital, LLC | 10% Owner | Buy | P | 9.61 | 520,291 | 4,999,997 | 2,716,840 | 2.2 M to 2.7 M (+23.69 %) |
Dec 28 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 8.06 | 496,277 | 3,999,993 | 2,293,371 | 1.8 M to 2.3 M (+27.62 %) |
Nov 12 2020 | TCON | Tracon Pharmaceuti ... | Ikarian Capital, LLC | 10% Owner | Buy | P | 7.53 | 5,000 | 37,629 | 2,196,549 | 2.2 M to 2.2 M (+0.23 %) |
Nov 12 2020 | TCON | Tracon Pharmaceuti ... | Ikarian Capital, LLC | 10% Owner | Buy | P | 4.64 | 21,300 | 98,907 | 2,191,549 | 2.2 M to 2.2 M (+0.98 %) |
Nov 12 2020 | TCON | Tracon Pharmaceuti ... | Ikarian Capital, LLC | 10% Owner | Buy | P | 4.77 | 7,700 | 36,734 | 2,170,249 | 2.2 M to 2.2 M (+0.36 %) |
Oct 23 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 4.40 | 5,656 | 24,869 | 1,797,094 | 1.8 M to 1.8 M (+0.32 %) |
Oct 23 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 4.40 | 3,000 | 13,191 | 225,000 | 222 K to 225 K (+1.35 %) |
Oct 23 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 4.40 | 5,656 | 24,869 | 1,797,094 | 1.8 M to 1.8 M (+0.32 %) |
Oct 23 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 4.40 | 3,000 | 13,191 | 225,000 | 222 K to 225 K (+1.35 %) |
Sep 25 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 4.44 | 21,000 | 93,276 | 1,785,438 | 1.8 M to 1.8 M (+1.19 %) |
Sep 25 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 4.44 | 534 | 2,372 | 228,000 | 227.5 K to 228 K (+0.23 %) |
Sep 25 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 4.83 | 55,000 | 265,815 | 1,764,438 | 1.7 M to 1.8 M (+3.22 %) |
Sep 25 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 4.83 | 2,200 | 10,633 | 227,466 | 225.3 K to 227.5 K (+0.98 %) |
Sep 25 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 4.72 | 107 | 505 | 186,882 | 186.8 K to 186.9 K (+0.06 %) |
Sep 25 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 4.72 | 4,893 | 23,094 | 186,775 | 181.9 K to 186.8 K (+2.69 %) |
Sep 15 2020 | TCON | Tracon Pharmaceuti ... | Ikarian Capital, LLC | 10% Owner | Buy | P | 3.93 | 78,201 | 307,017 | 2,162,549 | 2.1 M to 2.2 M (+3.75 %) |
Sep 15 2020 | TCON | Tracon Pharmaceuti ... | Ikarian Capital, LLC | 10% Owner | Buy | P | 3.49 | 79,415 | 277,460 | 2,084,348 | 2 M to 2.1 M (+3.96 %) |
Sep 15 2020 | TCON | Tracon Pharmaceuti ... | Ikarian Capital, LLC | 10% Owner | Buy | P | 2.90 | 13,244 | 38,408 | 2,004,933 | 2 M to 2 M (+0.66 %) |
Sep 15 2020 | TCON | Tracon Pharmaceuti ... | Ikarian Capital, LLC | 10% Owner | Buy | P | 2.87 | 151,611 | 434,502 | 1,991,689 | 1.8 M to 2 M (+8.24 %) |
Sep 14 2020 | TCON | Tracon Pharmaceuti ... | WIGGINS MARK C | Chief Business Offi ... | Buy | P | 4.14 | 7,000 | 28,953 | 12,350 | 5.4 K to 12.4 K (+130.84 %) |
Sep 09 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 3.47 | 45,000 | 156,101 | 1,709,438 | 1.7 M to 1.7 M (+2.70 %) |
Sep 09 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 3.47 | 2,500 | 8,672 | 225,266 | 222.8 K to 225.3 K (+1.12 %) |
Sep 09 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 2.88 | 8,492 | 24,497 | 1,664,438 | 1.7 M to 1.7 M (+0.51 %) |
Sep 09 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 2.88 | 566 | 1,633 | 222,766 | 222.2 K to 222.8 K (+0.25 %) |
Sep 09 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 2.55 | 5,000 | 12,750 | 181,882 | 176.9 K to 181.9 K (+2.83 %) |
Sep 09 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 2.60 | 5,000 | 13,000 | 176,882 | 171.9 K to 176.9 K (+2.91 %) |
Sep 03 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 2.35 | 115,000 | 270,756 | 1,655,946 | 1.5 M to 1.7 M (+7.46 %) |
Sep 03 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 2.35 | 4,800 | 11,301 | 222,200 | 217.4 K to 222.2 K (+2.21 %) |
Sep 03 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 2.04 | 38,600 | 78,906 | 1,540,946 | 1.5 M to 1.5 M (+2.57 %) |
Sep 03 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 2.04 | 1,400 | 2,862 | 217,400 | 216 K to 217.4 K (+0.65 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Option Exercise | P | 0.01 | 1,358,993 | 13,590 | 1,358,993 | |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Option Exercise | P | 0.01 | 1,358,993 | 13,590 | 1,358,993 | |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.84 | 150,000 | 275,370 | 1,502,346 | 1.4 M to 1.5 M (+11.09 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.84 | 150,000 | 275,370 | 1,502,346 | 1.4 M to 1.5 M (+11.09 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.84 | 6,000 | 11,015 | 216,000 | 210 K to 216 K (+2.86 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.84 | 6,000 | 11,015 | 216,000 | 210 K to 216 K (+2.86 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.67 | 146,150 | 244,071 | 1,352,346 | 1.2 M to 1.4 M (+12.12 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.67 | 146,150 | 244,071 | 1,352,346 | 1.2 M to 1.4 M (+12.12 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.78 | 60,000 | 106,974 | 210,000 | 150 K to 210 K (+40.00 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.78 | 60,000 | 106,974 | 210,000 | 150 K to 210 K (+40.00 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.71 | 35,408 | 60,434 | 1,206,196 | 1.2 M to 1.2 M (+3.02 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.71 | 35,408 | 60,434 | 1,206,196 | 1.2 M to 1.2 M (+3.02 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.71 | 147,946 | 252,514 | 150,000 | 2.1 K to 150 K (+7,202.82 %) |
Aug 31 2020 | TCON | Tracon Pharmaceuti ... | Opaleye Management Inc. | 10% Owner | Buy | P | 1.71 | 147,946 | 252,514 | 150,000 | 2.1 K to 150 K (+7,202.82 %) |
Aug 25 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.56 | 5,325 | 8,307 | 171,882 | 166.6 K to 171.9 K (+3.20 %) |
Aug 24 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.58 | 30,000 | 47,400 | 166,557 | 136.6 K to 166.6 K (+21.97 %) |
Aug 24 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.58 | 30,000 | 47,400 | 166,557 | 136.6 K to 166.6 K (+21.97 %) |
Aug 18 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.63 | 44,743 | 72,851 | 136,557 | 91.8 K to 136.6 K (+48.73 %) |
Aug 18 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.70 | 100 | 170 | 91,814 | 91.7 K to 91.8 K (+0.11 %) |
Aug 14 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.65 | 5,000 | 8,250 | 91,714 | 86.7 K to 91.7 K (+5.77 %) |
Aug 14 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.79 | 10,000 | 17,900 | 86,714 | 76.7 K to 86.7 K (+13.04 %) |
Aug 14 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.67 | 5,000 | 8,350 | 76,714 | 71.7 K to 76.7 K (+6.97 %) |
Aug 14 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.65 | 5,000 | 8,250 | 91,714 | 86.7 K to 91.7 K (+5.77 %) |
Aug 14 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.79 | 10,000 | 17,900 | 86,714 | 76.7 K to 86.7 K (+13.04 %) |
Aug 14 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.67 | 5,000 | 8,350 | 76,714 | 71.7 K to 76.7 K (+6.97 %) |
Jun 25 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.90 | 9,895 | 18,801 | 71,714 | 61.8 K to 71.7 K (+16.01 %) |
Jun 16 2020 | TCON | Tracon Pharmaceuti ... | LARUE WILLIAM R | Director | Option Exercise | A | 2.07 | 4,500 | 9,315 | 4,500 | |
Jun 16 2020 | TCON | Tracon Pharmaceuti ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 2.07 | 4,500 | 9,315 | 4,500 | |
Jun 16 2020 | TCON | Tracon Pharmaceuti ... | Twiford J Rainer | Director | Option Exercise | A | 2.07 | 4,500 | 9,315 | 4,500 | |
Jun 16 2020 | TCON | Tracon Pharmaceuti ... | WORLAND STEPHEN T | Director | Option Exercise | A | 2.07 | 4,500 | 9,315 | 4,500 | |
Jun 16 2020 | TCON | Tracon Pharmaceuti ... | Walker Paul Edward | Director | Option Exercise | A | 2.07 | 4,500 | 9,315 | 4,500 | |
Jun 16 2020 | TCON | Tracon Pharmaceuti ... | PELLETIER SAUNDRA L | Director | Option Exercise | A | 2.07 | 4,500 | 9,315 | 4,500 | |
Jun 16 2020 | TCON | Tracon Pharmaceuti ... | PELLETIER SAUNDRA L | Director | Buy | P | 2.07 | 3,000 | 6,209 | 5,500 | 2.5 K to 5.5 K (+120.00 %) |
Jun 16 2020 | TCON | Tracon Pharmaceuti ... | PELLETIER SAUNDRA L | Director | Buy | P | 2.00 | 2,500 | 5,000 | 2,500 | 0 to 2.5 K |
Mar 13 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.13 | 4,100 | 4,624 | 50,877 | 46.8 K to 50.9 K (+8.76 %) |
Mar 12 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.17 | 5,000 | 5,858 | 46,777 | 41.8 K to 46.8 K (+11.97 %) |
Mar 12 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.19 | 5,000 | 5,945 | 41,777 | 36.8 K to 41.8 K (+13.60 %) |
Mar 12 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.66 | 5,000 | 8,288 | 36,777 | 31.8 K to 36.8 K (+15.73 %) |
Mar 12 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.71 | 5,000 | 8,549 | 31,777 | 26.8 K to 31.8 K (+18.67 %) |
Mar 10 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 1.87 | 10,000 | 18,691 | 26,777 | 16.8 K to 26.8 K (+59.61 %) |
Feb 04 2020 | TCON | Tracon Pharmaceuti ... | Brown Scott B. | Chief Accounting Of ... | Option Exercise | A | 4.02 | 22,000 | 88,440 | 22,000 | |
Feb 04 2020 | TCON | Tracon Pharmaceuti ... | WIGGINS MARK C | Chief Business Offi ... | Option Exercise | A | 4.02 | 22,000 | 88,440 | 22,000 | |
Feb 04 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Option Exercise | A | 4.02 | 123,200 | 495,264 | 123,200 | |
Jan 24 2020 | TCON | Tracon Pharmaceuti ... | WIGGINS MARK C | Chief Business Offi ... | Buy | P | 4.02 | 5,000 | 20,103 | 5,000 | 0 to 5 K |
Jan 24 2020 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Payment of Exercise | F | 3.76 | 929 | 3,493 | 16,777 | 17.7 K to 16.8 K (-5.25 %) |
Dec 11 2019 | TCON | Tracon Pharmaceuti ... | Puissance Cross-Border Opportu ... | 10% Owner | Sell | S | 2.92 | 340,134 | 993,191 | 76,048 | 416.2 K to 76 K (-81.73 %) |
Dec 11 2019 | TCON | Tracon Pharmaceuti ... | Puissance Cross-Border Opportu ... | 10% Owner | Sell | S | 3.05 | 43,996 | 134,188 | 416,182 | 460.2 K to 416.2 K (-9.56 %) |
Aug 12 2019 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 0.45 | 50,000 | 22,500 | 173,565 | 123.6 K to 173.6 K (+40.46 %) |
Jun 17 2019 | TCON | Tracon Pharmaceuti ... | Walker Paul Edward | Director | Option Exercise | A | 0.64 | 15,000 | 9,525 | 15,000 | |
Jun 17 2019 | TCON | Tracon Pharmaceuti ... | LARUE WILLIAM R | Director | Option Exercise | A | 0.64 | 15,000 | 9,525 | 15,000 | |
Jun 17 2019 | TCON | Tracon Pharmaceuti ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 0.64 | 15,000 | 9,525 | 15,000 | |
Jun 17 2019 | TCON | Tracon Pharmaceuti ... | Twiford J Rainer | Director | Option Exercise | A | 0.64 | 15,000 | 9,525 | 15,000 | |
Jun 17 2019 | TCON | Tracon Pharmaceuti ... | WORLAND STEPHEN T | Director | Option Exercise | A | 0.64 | 15,000 | 9,525 | 15,000 | |
Jan 23 2019 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Payment of Exercise | F | 1.04 | 9,290 | 9,663 | 123,565 | 132.9 K to 123.6 K (-6.99 %) |
Jan 23 2019 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Payment of Exercise | F | 1.04 | 9,290 | 9,663 | 123,565 | 132.9 K to 123.6 K (-6.99 %) |
Dec 21 2018 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Buy | P | 0.66 | 49,000 | 32,222 | 132,855 | 83.9 K to 132.9 K (+58.43 %) |
Dec 03 2018 | TCON | Tracon Pharmaceuti ... | Puissance Cross-Border Opportu ... | 10% Owner | Buy | S | 1.21 | 4,326 | 5,234 | 4,601,768 | 4.6 M to 4.6 M (+0.09 %) |
Dec 03 2018 | TCON | Tracon Pharmaceuti ... | Puissance Cross-Border Opportu ... | 10% Owner | Buy | P | 1.13 | 4,326 | 4,888 | 4,606,094 | 4.6 M to 4.6 M (+0.09 %) |
Jun 13 2018 | TCON | Tracon Pharmaceuti ... | Wang Theodore T | Director | Option Exercise | A | 2.70 | 15,000 | 40,500 | 15,000 | |
Jun 13 2018 | TCON | Tracon Pharmaceuti ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 2.70 | 15,000 | 40,500 | 15,000 | |
Jun 13 2018 | TCON | Tracon Pharmaceuti ... | Walker Paul Edward | Director | Option Exercise | A | 2.70 | 15,000 | 40,500 | 15,000 | |
Jun 13 2018 | TCON | Tracon Pharmaceuti ... | LARUE WILLIAM R | Director | Option Exercise | A | 2.70 | 15,000 | 40,500 | 15,000 | |
Jun 13 2018 | TCON | Tracon Pharmaceuti ... | Twiford J Rainer | Director | Option Exercise | A | 2.70 | 15,000 | 40,500 | 15,000 | |
Jun 13 2018 | TCON | Tracon Pharmaceuti ... | WORLAND STEPHEN T | Director | Option Exercise | A | 2.70 | 15,000 | 40,500 | 15,000 | |
May 30 2018 | TCON | Tracon Pharmaceuti ... | WIGGINS MARK C | Chief Business Offi ... | Option Exercise | A | 2.75 | 280,000 | 770,000 | 280,000 | |
Apr 09 2018 | TCON | Tracon Pharmaceuti ... | Wang Theodore T | Director | Option Exercise | A | 2.55 | 25,000 | 63,750 | 25,000 | |
Apr 09 2018 | TCON | Tracon Pharmaceuti ... | Wang Theodore T | Director | Option Exercise | A | 2.55 | 25,000 | 63,750 | 25,000 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | Viswanathan Ravi | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | Sonsini Peter W. | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | Sonsini Peter W. | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | MOTT DAVID M | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | MOTT DAVID M | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | KERINS PATRICK J | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | KERINS PATRICK J | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | BASKETT FOREST | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | BASKETT FOREST | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | BARRIS PETER J | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | BARRIS PETER J | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | BARRETT M JAMES | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | BARRETT M JAMES | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Feb 23 2018 | TCON | Tracon Pharmaceuti ... | BITAR PATRICIA L | CFO | Option Exercise | A | 2.15 | 95,000 | 204,250 | 95,000 | |
Feb 23 2018 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Option Exercise | A | 2.15 | 225,000 | 483,750 | 225,000 | |
Jan 23 2018 | TCON | Tracon Pharmaceuti ... | LOGAN H CASEY | Chief Business Offi ... | Payment of Exercise | F | 2.95 | 3,317 | 9,785 | 27,754 | 31.1 K to 27.8 K (-10.68 %) |
Jan 23 2018 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Payment of Exercise | F | 2.95 | 9,290 | 27,406 | 76,855 | 86.1 K to 76.9 K (-10.78 %) |
Jan 23 2018 | TCON | Tracon Pharmaceuti ... | BITAR PATRICIA L | CFO | Payment of Exercise | F | 2.95 | 3,317 | 9,785 | 29,636 | 33 K to 29.6 K (-10.07 %) |
Jun 15 2017 | TCON | Tracon Pharmaceuti ... | Twiford J Rainer | Director | Option Exercise | A | 2.15 | 15,000 | 32,250 | 15,000 | |
Jun 15 2017 | TCON | Tracon Pharmaceuti ... | Walker Paul Edward | Director | Option Exercise | A | 2.15 | 15,000 | 32,250 | 15,000 | |
Jun 15 2017 | TCON | Tracon Pharmaceuti ... | LARUE WILLIAM R | Director | Option Exercise | A | 2.15 | 15,000 | 32,250 | 15,000 | |
Jun 15 2017 | TCON | Tracon Pharmaceuti ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 2.15 | 15,000 | 32,250 | 15,000 | |
Jun 15 2017 | TCON | Tracon Pharmaceuti ... | WORLAND STEPHEN T | Director | Option Exercise | A | 2.15 | 15,000 | 32,250 | 15,000 | |
Jun 05 2017 | TCON | Tracon Pharmaceuti ... | LARUE WILLIAM R | Director | Sell | S | 2.69 | 2,500 | 6,733 | 13,388 | 15.9 K to 13.4 K (-15.74 %) |
Jan 24 2017 | TCON | Tracon Pharmaceuti ... | LOGAN H CASEY | Chief Business Offi ... | Option Exercise | A | 5.15 | 55,000 | 283,250 | 55,000 | |
Jan 24 2017 | TCON | Tracon Pharmaceuti ... | LOGAN H CASEY | Chief Business Offi ... | Payment of Exercise | F | 4.85 | 3,552 | 17,227 | 31,071 | 34.6 K to 31.1 K (-10.26 %) |
Jan 24 2017 | TCON | Tracon Pharmaceuti ... | BITAR PATRICIA L | CFO | Option Exercise | A | 5.15 | 55,000 | 283,250 | 55,000 | |
Jan 24 2017 | TCON | Tracon Pharmaceuti ... | BITAR PATRICIA L | CFO | Payment of Exercise | F | 4.85 | 3,552 | 17,227 | 30,543 | 34.1 K to 30.5 K (-10.42 %) |
Jan 24 2017 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Option Exercise | A | 5.15 | 190,000 | 978,500 | 190,000 | |
Jan 24 2017 | TCON | Tracon Pharmaceuti ... | THEUER CHARLES | President and CEO | Payment of Exercise | F | 4.85 | 9,870 | 47,870 | 86,145 | 96 K to 86.1 K (-10.28 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | BARRETT M JAMES | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | BARRIS PETER J | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | BASKETT FOREST | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | KERINS PATRICK J | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | MOTT DAVID M | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | SANDELL SCOTT D | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | Sonsini Peter W. | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | Viswanathan Ravi | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |